Mellon HBV Alternative Strategies LLC, a subsidiary of Mellon Financial Corporation, announced that it has established a specialist research team in Hong Kong to cover Asian markets.
Andy Shpiz, Asian research director for Mellon HBV, will lead a team of three Mellon research analysts: Eddie Hui, fluent in Mandarin and Cantonese; Shen Lin, fluent in Mandarin; and Shizuka Lisa Saito, who is based in London and fluent in Japanese. Shpiz and Lin have been assigned to Mellon Global Investments (MGI) Asia Limited’s Hong Kong office on a temporary basis, where they will join MGI Asia’s Hui to conduct research on Asia opportunities for Mellon HBV’s portfolio managers.
“Asia is the next frontier for us,” said Mickey Harley, chief executive officer at Mellon HBV. “With HBV now having access to local research provided by its MGI Asia affiliate, we are well positioned to capitalize on the many event-driven opportunities in the region.”